Skip to main content
. 2019 Aug 19;11(8):419. doi: 10.3390/pharmaceutics11080419

Figure 1.

Figure 1

Morphological and physical characteristics of TA microcrystals. (A) Size distribution of the drug microcrystals stabilized by BKC, (B) XRD patterns of (a) TA raw material, (b) BKC powder, and (c) TA microcrystals, SEM images of (C) TA raw material, and (D) TA microcrystals stabilized by BKC at the concentration of 0.1 w/v %.